Compare LUNG & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LUNG | GHI |
|---|---|---|
| Founded | 1995 | 1998 |
| Country | United States | United States |
| Employees | N/A | 5 |
| Industry | Industrial Specialties | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.1M | 142.3M |
| IPO Year | 2020 | 1998 |
| Metric | LUNG | GHI |
|---|---|---|
| Price | $1.95 | $5.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | $5.38 | ★ $10.50 |
| AVG Volume (30 Days) | ★ 284.9K | 37.5K |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 22.93% |
| EPS Growth | ★ 7.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $90,497,000.00 | $85,389,766.00 |
| Revenue This Year | $2.48 | $273.95 |
| Revenue Next Year | $18.46 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 8.01 | N/A |
| 52 Week Low | $1.13 | $4.71 |
| 52 Week High | $2.89 | $10.79 |
| Indicator | LUNG | GHI |
|---|---|---|
| Relative Strength Index (RSI) | 43.64 | 42.99 |
| Support Level | $1.20 | $5.85 |
| Resistance Level | $2.16 | $6.17 |
| Average True Range (ATR) | 0.12 | 0.15 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 26.32 | 14.50 |
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.